The cytotoxicity of IMB5043 in various tumor cells also involved the Chk2-mediated G2/M phase cell-cycle arrest and downstream apoptosis induction.97, 98, 99 A novel therapeutic method aimed at targeting Chk2-null CRC cells was developed by Ahmad et al. This evidence concerns the gene CHEK2 and colorectal carcinoma.